NTRA
Natera, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$262.63-3.23%
Price as of Jul 20, 2026
NTRA growth
Natera, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +36.6%
- EBITDA
- -51.6%
- EBIT
- -42.7%
- EPS
- -10.9%
- Free cash flow
- +8.0%
- Operating cash flow
- +37.8%
Forward estimates
- Revenue
- +15.1%
- EBITDA
- —
- EPS
- +37.5%
Three-year CAGR
- Revenue
- +41.1%
- EBITDA
- -48.9%
- EBIT
- -39.4%
- Net income
- -9.3%
- EPS
- +0.7%
- Free cash flow
- +57.6%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.